HANNAH JOHNSON: Open Payments
NPI 1588194708 · PHILADELPHIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 59 payments from 11 companies in 2025. Trend: 2023 $947 · 2024 $1,007 · 2025 $1,028
Food & beverage: $1,028
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $367 |
| Lilly USA, LLC | 11 | $146 |
| ABBVIE INC. | 5 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| PFIZER INC. | 5 | $82 |
| Amgen Inc. | 5 | $73 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Novo Nordisk Inc | 3 | $60 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: FARXIGA, AIRSUPRA, MOUNJARO, BREZTRI, Kerendia, NURTEC ODT, Ozempic, TRELEGY ELLIPTA.
Industry payments across MS — which companies pay providers there.
